nach oben

Erschienen in:

01.12.2011 | Original Article

Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients

verfasst von: Masaki Ohya, Haruhisa Otani, Keigo Kimura, Yasushi Saika, Ryoichi Fujii, Susumu Yukawa, Takashi Shigematsu

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Vascular calcification is a feature of arteriosclerosis. In hemodialysis (HD) patients, vascular calcification progresses rapidly. This study used the aortic calcification area index (ACAI), an index of vascular calcification, to evaluate vascular calcification factors in HD patients, to investigate correlations between ACAI and long-term prognosis and to assess correlations between various factors and long-term prognosis.

Methods

Subjects comprised 137 patients on maintenance HD. ACAI was measured as an index of vascular calcification as measured by abdominal plain computed tomography. The patients were divided into a high ACAI (H) group and a low ACAI (L) group according to whether the ACAI was below or above the mean value (21.4%) of ACAI, and long-term all-cause death and cardiovascular death rates were compared between groups. Risk factors for all-cause death and cardiovascular death were examined by Cox hazard analysis.

Results

During follow-up (mean follow-up period 95.3 ± 50.3 months), 76 patients died, including 46 cardiovascular deaths. Deaths included 51 of 70 patients (67.1%) in Group H and 25 of 67 patients (37.3%) in Group L. Cardiovascular death rates were 51.4 and 14.9%, respectively. On Kaplan–Meier analysis, the number of all-cause deaths was significantly higher in Group H (P < 0.001, log-rank test). Similarly, the number of cardiovascular deaths was significantly higher in Group H. Multivariate Cox proportional hazards analysis showed that ACAI (%) was a significant prognostic indicator for cardiovascular death (hazard ratio 1.03; 95% confidence interval 1.00–1.06, P = 0.03).

Conclusion

High ACAI was clearly correlated with mortality rate in HD patients, particularly cardiovascular mortality rate. ACAI was a useful long-term prognostic indicator in HD patients.

Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;18:1478–83.CrossRef

Nakai S, Masakane I, Akiba T, Iseki K, Watanabe Y, Itami N, et al. Overview of regular dialysis treatment in Japan ( as of 31 December 2005). Ther Apher Dial. 2007;11:411–41PubMedCrossRef

Yukawa S, Sonobe M, Yukawa A, Mimura K, Mune M, Maeda H, et al. Prevention of aortic calcification in patients on hemodialysis by long-term administration of vitamin E. J Nutr Sci Vitam. 1992;38(Suppl):S187–90.CrossRef

Taniwaki H, Ishimura E, Tabata T, Tsujimoto Y, Shioi A, Shoji T, et al. Aortic calcification in haemodialysis patients with diabetes mellitus. Nephrol Dial Transpl. 2005;20(11):2472–8.CrossRef

Ohya M, Otani H, Kimura K, Saika Y, Yukawa S, Shigematsu T, et al. Improved assessment of aortic calcification in Japanese patients undergoing maintenance hemodialysis. Intern Med. 2010;49(19):2071–5.PubMedCrossRef

Go AS, Chrtow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.PubMedCrossRef

Foley R, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(Suppl):S112–9.PubMedCrossRef

Shigematsu T, Kono T, Satoh K, Yokoyama K, Yoshida T, Hosoya T, et al. Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients. Nephrol Dial Transpl. 2003;18(Suppl 3):iii86–9.

London GM, Guerin AP, Marhais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl. 2003;18:1731–40.CrossRef

10.

Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39:695–701.PubMedCrossRef

11.

Yokoyama K, Nishioka M, Sakuma T, Yoshida S, Iida R, Yoshida H, et al. Most patients with coronary artery calcification have no coronary artery stenosis and hyperphosphatemia should be important in reevaluating the K/DOQI guideline. Ther Apher Dial. 2006;10:101.PubMedCrossRef

12.

Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2007;49(3):417–25.PubMedCrossRef

13.

Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, et al. Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol. 2010;42(1):187–94.PubMedCrossRef

14.

K/DOQI Workgroup. Clinical practice guideline for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(3):S62–84.

15.

Qunibi WY. Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD). Kidney Int Suppl. 2004;90:S8–12.PubMedCrossRef

16.

Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112:2627–33.PubMedCrossRef

17.

Mathew S, Tustison KS, Sugatani T, et al. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol. 2008;19:1092–105.PubMedCrossRef

18.

Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcification in end-stage renal disease. Nephrol Dial Transpl. 2000;15:1014–21.CrossRef

19.

Mattace-Raso FU, van der Cammen JM, Hofman A, van Popele NM, Bos ML, Schalekamp MADH, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113:657–63.PubMedCrossRef

20.

London GM. Large arteries hemodynamics: conduit versus cushioning function. Blood Press Suppl. 1997;2:48–51.PubMed

21.

Westerhof N, O’Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995;13:943–52.PubMedCrossRef

22.

Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y. Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol. 1993;21:1497–506.PubMedCrossRef

Titel: Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients
verfasst von: Masaki Ohya
Haruhisa Otani
Keigo Kimura
Yasushi Saika
Ryoichi Fujii
Susumu Yukawa
Takashi Shigematsu
Publikationsdatum: 01.12.2011
Verlag: Springer Japan
Erschienen in: Clinical and Experimental Nephrology / Ausgabe 6/2011
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI: https://doi.org/10.1007/s10157-011-0517-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients